SOLD - 6,500 sq ft standard processor in E. Nova Scotia with rec sales & SMP licences for $399K
Low priced opportunity to acquire a proven, turnkey, standard processor with rec sales and medical sales licences for $399K o.b.o. Possible option to lease. MOVE QUICK ON THIS BARGAIN!
Listing ID:
15482078557
Licence(s) Held:
Standard Cultivation, Standard Processing, Sale for Medical Purposes, Recreational Sales Amendment, CRA Licence
Listing Details:
Well-designed, wholly-owned 6,500+ ft.², licensed processor with rec sales and medical sales licences located in Eastern Nova Scotia
Sitting on ~16 acres and offering high-volume production capability for premium flower and pre-roll production, co-manufacturing, and processing/packaging
Facility has seven licensed processing rooms with three separate secure storage areas
Facility is flexible and can accommodate full-scale manufacturing, packaging, extraction, or a combination
~$2 million capital investment has been made on the customized cannabis build-out and fit-out
Property assessment for tax purposes is $352,500
Ability for the new owner to utilize the services of several existing security clearance holders to optimize licensing continuity
Building can be expanded in the future
Bargain-priced at $399K o.b.o.
May be open to lease options
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.